{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:09:33Z","timestamp":1792501773999,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.critrevonc.2025.105070","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T08:09:58Z","timestamp":1764922198000},"page":"105070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The crosstalk between ferroptosis and the immune system in urological cancers: Mechanisms, prognostic value, and therapeutic implications"],"prefix":"10.1016","volume":"218","author":[{"given":"Shuwen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.critrevonc.2025.105070_bib1","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105070_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40164-023-00427-w","article-title":"Ferroptosis: a novel regulated cell death participating in cellular stress response, radiotherapy, and immunotherapy","volume":"12","author":"Zheng","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105070_bib4","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","article-title":"Ferroptosis: machinery and regulation","volume":"17","author":"Chen","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.critrevonc.2025.105070_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123746","article-title":"KAT2A-mediated H3K79 succinylation promotes ferroptosis in diabetic nephropathy by regulating SAT2","volume":"376","author":"Peng","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.critrevonc.2025.105070_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.792827","article-title":"Ferroptosis in lung cancer: from molecular mechanisms to prognostic and therapeutic opportunities","volume":"11","author":"Tabnak","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-025-04198-7","article-title":"piR-16404 drives ferroptotic liver injury via CASTOR1\/mTORC1\/GPX4 dysregulation in HepG2 cells and mice: a novel toxicity mechanism of N, N-dimethylformamide","author":"Ma","year":"2025","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib8","article-title":"Tumor microenvironment: Nurturing cancer cells for immunoevasion and druggable vulnerabilities for cancer immunotherapy","volume":"611","author":"Yu","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2120676","article-title":"Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness","volume":"11","author":"Barnestein","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.critrevonc.2025.105070_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","article-title":"Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy","volume":"470","author":"Lei","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2025.105070_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2024.108198","article-title":"Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma","volume":"171","author":"Gong","year":"2024","journal-title":"Comput. Biol. Med"},{"issue":"14","key":"10.1016\/j.critrevonc.2025.105070_bib12","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.7150\/thno.76854","article-title":"Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib13","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-024-02212-7","article-title":"Resistance mechanisms to immune checkpoint inhibitors: updated insights","volume":"24","author":"Alsaafeen","year":"2025","journal-title":"Mol. Cancer"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105070_bib14","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.62347\/MJOA5699","article-title":"Predictive and prognostic value of combined detection of sTim-3, PG and PD-L1 in immune checkpoint inhibitor therapy for advanced gastric cancer","volume":"16","author":"Zhang","year":"2024","journal-title":"Am. J. Transl. Res"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.105070_bib15","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/s41590-024-01999-3","article-title":"Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism","volume":"25","author":"Peralta","year":"2024","journal-title":"Nat. Immunol. [Internet]"},{"key":"10.1016\/j.critrevonc.2025.105070_bib16","article-title":"Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: current research and future perspective","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1119369","article-title":"Ferroptosis and tumor immunotherapy: a promising combination therapy for tumors","volume":"13","author":"Cai","year":"2023","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41420-025-02415-x","article-title":"Ferroptosis: CD8+T cells\u2019 blade to destroy tumor cells or poison for self-destruction","volume":"11","author":"Liang","year":"2025","journal-title":"Cell Death Discov. [Internet]"},{"key":"10.1016\/j.critrevonc.2025.105070_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103796","article-title":"Ferroptosis triggers anti-tumor immunity via promoting chaperone-mediated autophagic degradation of SHP2","volume":"86","author":"Zhu","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cytogfr.2025.06.007","article-title":"Ferroptosis in immune cells: Implications for tumor immunity and cancer therapy","volume":"84","author":"Gao","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.critrevonc.2025.105070_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117298","article-title":"Firing up \u201ccold\u201d tumors: Ferroptosis causes immune activation by improving T cell infiltration","volume":"179","author":"Li","year":"2024","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.critrevonc.2025.105070_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100296","article-title":"Circulating miRNAs in genitourinary cancer: pioneering advances in early detection and diagnosis","volume":"8","author":"Cicatiello","year":"2025","journal-title":"J. Liq. Biopsy"},{"key":"10.1016\/j.critrevonc.2025.105070_bib23","unstructured":"Leslie S.W., Soon-Sutton T.L., Skelton W.P. Prostate Cancer. In Treasure Island (FL); 2025."},{"key":"10.1016\/j.critrevonc.2025.105070_bib24","article-title":"Revealing the role of bisphenol A on prostate cancer progression and identifying potential targets: a comprehensive analysis from population cohort to molecular mechanism","author":"Zhou","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105070_bib25","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.21037\/tau-24-415","article-title":"Ferroptosis-related gene signature predicts prognosis and immune microenvironment in prostate cancer","volume":"13","author":"Wang","year":"2024","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib26","article-title":"Identification and validation of a prognostic signature for prostate cancer based on ferroptosis-related genes","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib27","article-title":"A NOvel Ferroptosis-based Molecular Signature Associated with Biochemical Recurrence-free Survival and Tumor Immune Microenvironment of Prostate Cancer","volume":"9","author":"Ke","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib28","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1186\/s12885-022-09876-8","article-title":"The ferroptosis-related long non-coding RNAs signature predicts biochemical recurrence and immune cell infiltration in prostate cancer","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2025.105070_bib29","article-title":"A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.803766","article-title":"A ferroptosis-related gene prognostic index associated with biochemical recurrence and radiation resistance for patients with prostate cancer undergoing radical radiotherapy","volume":"10","author":"Feng","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105070_bib31","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.21037\/tau-22-454","article-title":"Establishment of a novel prognostic prediction model through bioinformatics analysis for prostate cancer based on ferroptosis-related genes and its application in immune cell infiltration","volume":"11","author":"Yang","year":"2022","journal-title":"Transl. Androl. Urol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e23495","article-title":"Establishment of novel ferroptosis-related prognostic subtypes correlating with immune dysfunction in prostate cancer patients","volume":"10","author":"Feng","year":"2024","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105070_bib33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/tox.23997","article-title":"MT1G, an emerging ferroptosis-related gene: A novel prognostic biomarker and indicator of immunotherapy sensitivity in prostate cancer","volume":"39","author":"Cheng","year":"2024","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib34","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s12672-025-02484-5","article-title":"Development of a machine learning-based predictive risk model combining fatty acid metabolism and ferroptosis for immunotherapy response and prognosis in prostate cancer","volume":"16","author":"Wang","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib35","article-title":"Development of a novel risk signature for predicting the prognosis and immunotherapeutic response of prostate cancer by integrating ferroptosis and immune-related genes","author":"Song","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100305","article-title":"Blood and urine-based biomarkers in prostate cancer: current advances, clinical applications, and future directions","volume":"9","author":"Crocetto","year":"2025","journal-title":"J. Liq. Biopsy"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105070_bib37","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3892\/ol.2025.15191","article-title":"Effect of TP53 mutation, expression and polymorphism on the survival, immune infiltration and ferroptosis in patients with prostate cancer","volume":"30","author":"Wen","year":"2025","journal-title":"Oncol. Lett."},{"issue":"23","key":"10.1016\/j.critrevonc.2025.105070_bib38","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.1158\/0008-5472.CAN-20-3607","article-title":"Supraphysiologic testosterone induces ferroptosis and activates immune pathways through nucleophagy in prostate cancer","volume":"81","author":"Kumar","year":"2021","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105070_bib39","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.apsb.2021.07.016","article-title":"Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8(+) T cell-mediated ferroptosis in castration-resistant prostate cancer","volume":"12","author":"Zhou","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105070_bib40","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.7150\/ijbs.92988","article-title":"The BUrgeoning Significance of Liquid-liquid Phase Separation in the Pathogenesis and Therapeutics of Cancers","volume":"20","author":"Xu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.critrevonc.2025.105070_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176007","article-title":"Evodiamine impairs HIF1A histone lactylation to inhibit Sema3A-mediated angiogenesis and PD-L1 by inducing ferroptosis in prostate cancer","volume":"957","author":"Yu","year":"2023","journal-title":"Eur. J. Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13045-023-01442-4","article-title":"Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis","volume":"16","author":"Ye","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105070_bib43","article-title":"Taurine Inhibits Ferroptosis Mediated by the Crosstalk between Tumor Cells and Tumor-Associated Macrophages in Prostate Cancer","volume":"11","author":"Xiao","year":"2024","journal-title":"Adv. Sci. (Weinh. Baden. Wurtt. Ger."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13046-024-03063-2","article-title":"Icaritin-curcumol activates CD8(+) T cells through regulation of gut microbiota and the DNMT1\/IGFBP2 axis to suppress the development of prostate cancer","volume":"43","author":"Xu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res"},{"issue":"1\u20132","key":"10.1016\/j.critrevonc.2025.105070_bib45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s10495-023-01885-7","article-title":"N(6)-methyladenosine regulator YTHDF1 represses the CD8\u2009+\u2009T cell-mediated antitumor immunity and ferroptosis in prostate cancer via m(6)A\/PD-L1 manner","volume":"29","author":"Wang","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.critrevonc.2025.105070_bib46","article-title":"Regulation of macrophage plasticity by circCCDC719-13 through HSP90 inhibition suppresses prostate cancer progression and metastasis: a translational study","author":"Cheng","year":"2025","journal-title":"Int J. Surg."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib47","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41467-025-57190-1","article-title":"Engineering nanozyme immunomodulator with magnetic targeting effect for cascade-enzyodynamic and ultrasound-reinforced metallo-immunotherapy in prostate carcinoma","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.105070_bib48","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/cac2.12321","article-title":"The establishment of polypeptide PSMA-targeted chimeric antigen receptor-engineered natural killer cells for castration-resistant prostate cancer and the induction of ferroptosis-related cell death","volume":"42","author":"Wu","year":"2022","journal-title":"Cancer Commun (London England)"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib49","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s12951-022-01635-y","article-title":"Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer","volume":"20","author":"Kim","year":"2022","journal-title":"J. Nanobiotechnology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib50","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12951-024-02496-3","article-title":"Irradiated microparticles suppress prostate cancer by tumor microenvironment reprogramming and ferroptosis","volume":"22","author":"Deng","year":"2024","journal-title":"J. Nanobiotechnology"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105070_bib51","doi-asserted-by":"crossref","first-page":"7213","DOI":"10.1021\/acsnano.4c16981","article-title":"Nanovesicles for Lipid Metabolism Reprogram-Enhanced Ferroptosis and Magnetotherapy of Refractory Tumors and Inhibiting Metastasis with Activated Innate Immunity","volume":"19","author":"Cheng","year":"2025","journal-title":"ACS Nano"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105070_bib52","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.105070_bib53","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder Cancer: A Review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105070_bib54","article-title":"Incidental paraganglioma of the urinary bladder: A case series highlighting a rare entity and a urologist\u2019s nightmare","volume":"12","author":"Mehmood","year":"2025","journal-title":"Bl. (San. Fr. Calif."},{"key":"10.1016\/j.critrevonc.2025.105070_bib55","article-title":"Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer","volume":"8","author":"Liu","year":"2021","journal-title":"Front Mol. Biosci."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib56","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1186\/s12935-021-02096-3","article-title":"A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration","volume":"21","author":"Luan","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105070_bib57","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3892\/ol.2022.13421","article-title":"Prognostic value and potential biological functions of ferroptosis-related gene signature in bladder cancer","volume":"24","author":"Wang","year":"2022","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib58","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1186\/s12885-021-08687-7","article-title":"A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer","volume":"21","author":"Liang","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2025.105070_bib59","article-title":"A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer","volume":"11","author":"Yang","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.712230","article-title":"A Novel Ferroptosis-Related Prognostic Signature Reveals Macrophage Infiltration and EMT Status in Bladder Cancer","volume":"9","author":"Yan","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.105070_bib61","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.18632\/aging.204385","article-title":"Development and validation of a novel model for predicting the survival of bladder cancer based on ferroptosis-related genes","volume":"14","author":"Li","year":"2022","journal-title":"Aging (Albany NY)"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.105070_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/genes13061073","article-title":"Robust Prediction of Prognosis and Immunotherapy Response for Bladder Cancer through Machine Learning Algorithm","volume":"13","author":"Hu","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.critrevonc.2025.105070_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.726486","article-title":"A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105070_bib64","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/tox.23949","article-title":"Generalized machine learning based on multi-omics data to profile the effect of ferroptosis pathway on prognosis and immunotherapy response in patients with bladder cancer","volume":"39","author":"Liu","year":"2024","journal-title":"Environ. Toxicol."},{"issue":"42","key":"10.1016\/j.critrevonc.2025.105070_bib65","article-title":"Construction and multiple validations of a robust ferroptosis-related prognostic model in bladder cancer: A comprehensive study","volume":"103","author":"Dai","year":"2024","journal-title":"Med. (Baltim. )"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib66","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12894-023-01354-y","article-title":"Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment","volume":"24","author":"Ma","year":"2024","journal-title":"BMC Urol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib67","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1031906","article-title":"Development of a Ferroptosis-Related lncRNA Signature to Predict the Prognosis and Immune Landscape of Bladder Cancer","volume":"2021","author":"Zhou","year":"2021","journal-title":"Dis. Markers"},{"key":"10.1016\/j.critrevonc.2025.105070_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.699804","article-title":"A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients","volume":"9","author":"Chen","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12957-022-02514-4","article-title":"Predictive role of ferroptosis-related long non-coding RNAs in bladder cancer and their association with immune microenvironment and immunotherapy response","volume":"20","author":"Liu","year":"2022","journal-title":"World J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105070_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24389","article-title":"Constructing an immune- and ferroptosis-related lncRNA signature to predict the immune landscape of human bladder cancer","volume":"36","author":"Li","year":"2022","journal-title":"J. Clin. Lab Anal."},{"key":"10.1016\/j.critrevonc.2025.105070_bib71","article-title":"Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer","volume":"10","author":"Liu","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib72","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1038\/s41598-022-12712-5","article-title":"Quantification of ferroptosis pattern in bladder carcinoma and its significance on immunotherapy","volume":"12","author":"Cheng","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2025.105070_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.832892","article-title":"Ferroptosis Patterns and Tumor Microenvironment Infiltration Characterization in Bladder Cancer","volume":"10","author":"Xia","year":"2022","journal-title":"Front Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib74","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s40537-022-00641-z","article-title":"Identification of mRNA vaccines and conserved ferroptosis related immune landscape for individual precision treatment in bladder cancer","volume":"9","author":"Gui","year":"2022","journal-title":"J. big data"},{"key":"10.1016\/j.critrevonc.2025.105070_bib75","article-title":"Systematical analysis of ferroptosis regulators and identification of GCLM as a tumor promotor and immunological biomarker in bladder cancer","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib76","article-title":"Integrating single-cell transcriptomics to reveal the ferroptosis regulators in the tumor microenvironment that contribute to bladder urothelial carcinoma progression and immunotherapy","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib77","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1186\/s12885-024-12820-7","article-title":"APOL6 predicts immunotherapy efficacy of bladder cancer by ferroptosis","volume":"24","author":"Fan","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2025.105070_bib78","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241246649","article-title":"Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth","volume":"23","author":"Wu","year":"2024","journal-title":"Technol. Cancer Res Treat."},{"issue":"17","key":"10.1016\/j.critrevonc.2025.105070_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37638","article-title":"Disulfidptosis and ferroptosis related genes define the immune microenvironment and NUBPL serves as a potential biomarker for predicting prognosis and immunotherapy response in bladder cancer","volume":"10","author":"Zhang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.critrevonc.2025.105070_bib80","doi-asserted-by":"crossref","DOI":"10.1177\/15330338241305434","article-title":"Transcriptional Regulation of NUPR1 by MYH11 Activates PI3\u2005K\/AKT and Promotes Bladder Cancer Progression Through Ferroptosis and M2 Polarization of Macrophages","volume":"24","author":"Zhang","year":"2025","journal-title":"Technol. Cancer Res Treat."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib81","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12951-022-01575-7","article-title":"Iron oxide@chlorophyll clustered nanoparticles eliminate bladder cancer by photodynamic immunotherapy-initiated ferroptosis and immunostimulation","volume":"20","author":"Chin","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.critrevonc.2025.105070_bib82","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2023.09.024","article-title":"Mitochondrial-targeted brequinar liposome boosted mitochondrial-related ferroptosis for promoting checkpoint blockade immunotherapy in bladder cancer","volume":"363","author":"Ding","year":"2023","journal-title":"J. Control Release J. Control Release Soc."},{"key":"10.1016\/j.critrevonc.2025.105070_bib83","article-title":"Enhanced efficacy of immune checkpoint inhibitors by folate-targeted multifunctional drug through synergistic therapy inducing ferroptosis and immunogenic cell death in bladder cancer","volume":"31","author":"Shi","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.critrevonc.2025.105070_bib84","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.adu2836","article-title":"A Multifunctional Fe-EGCG@RSL3 Nanomedicine Synergizes Ferroptosis Induction and Tumor Microenvironment Remodeling for Enhanced Bladder Cancer Immunotherapy","volume":"8","author":"Zhang","year":"2025","journal-title":"Res (Wash. DC)"},{"key":"10.1016\/j.critrevonc.2025.105070_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.114954","article-title":"Bimetallic nanozyme-mediated dual ferroptosis\/cuproptosis synergy potentiates immunotherapy in bladder cancer","volume":"255","author":"Chen","year":"2025","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.critrevonc.2025.105070_bib86","article-title":"Molecular mechanisms of renal cell carcinoma metastasis and potential targets for therapy","volume":"13","author":"Li","year":"2025","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib87","article-title":"A Novel Ferroptosis-Related Pathway for Regulating Immune Checkpoints in Clear Cell Renal Cell Carcinoma","volume":"11","author":"Gao","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib88","doi-asserted-by":"crossref","unstructured":"Chen J.Y., Yiu W.H., Tang P.M.K., Tang S.C.W. New insights into fibrotic signaling in renal cell carcinoma. Front Cell Dev Biol [Internet]. 2023;Volume 11. Available from: \u3008https:\/\/www.frontiersin.org\/journals\/cell-and-developmental-biology\/articles\/10.3389\/fcell.2023.1056964\u3009.","DOI":"10.3389\/fcell.2023.1056964"},{"key":"10.1016\/j.critrevonc.2025.105070_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.851312","article-title":"Comprehensive Analysis of Ferroptosis- and Immune-Related Signatures to Improve the Prognosis and Diagnosis of Kidney Renal Clear Cell Carcinoma","volume":"13","author":"Xing","year":"2022","journal-title":"Front Immunol."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.105070_bib90","first-page":"5982","article-title":"Comprehensive analysis of immune ferroptosis gene in renal clear cell carcinoma: prognosis and influence of tumor microenvironment","volume":"14","author":"Yang","year":"2022","journal-title":"Am. J. Transl. Res"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.105070_bib91","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.21037\/tau-23-346","article-title":"Construction of a two-gene prognostic model related to ferroptosis in renal cell carcinoma","volume":"12","author":"Li","year":"2023","journal-title":"Transl. Androl. Urol."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105070_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2024.130706","article-title":"COPZ1 regulates ferroptosis through NCOA4-mediated ferritinophagy in lung adenocarcinoma","volume":"1868","author":"Wu","year":"2024","journal-title":"Biochim Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.critrevonc.2025.105070_bib93","article-title":"Comprehensive Analysis of Ferroptosis Regulators With Regard to PD-L1 and Immune Infiltration in Clear Cell Renal Cell Carcinoma","volume":"9","author":"Wang","year":"2021","journal-title":"Front Cell Dev. Biol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib94","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.649347","article-title":"Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma","volume":"11","author":"Chang","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib95","article-title":"A New Prognostic Risk Signature of Eight Ferroptosis-Related Genes in the Clear Cell Renal Cell Carcinoma","volume":"11","author":"Chen","year":"2021","journal-title":"Front Oncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2025.105070_bib96","doi-asserted-by":"crossref","first-page":"19789","DOI":"10.18632\/aging.203390","article-title":"Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma","volume":"13","author":"Zheng","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.critrevonc.2025.105070_bib97","article-title":"Ferroptosis-Related Gene-Based Prognostic Model and Immune Infiltration in Clear Cell Renal Cell Carcinoma","volume":"12","author":"Zhao","year":"2021","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.105070_bib98","first-page":"289","article-title":"Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients","volume":"19","author":"Tang","year":"2022","journal-title":"Urol. J."},{"issue":"11\u201312","key":"10.1016\/j.critrevonc.2025.105070_bib99","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s10495-022-01766-5","article-title":"Identification of ferroptosis-related signature with potential implications in prognosis and immunotherapy of renal cell carcinoma","volume":"27","author":"Liu","year":"2022","journal-title":"Apoptosis"},{"issue":"17","key":"10.1016\/j.critrevonc.2025.105070_bib100","first-page":"6176","article-title":"A nomogram integrating ferroptosis-and immune-related biomarker for prediction of prognosis and diagnosis in kidney renal clear cell carcinoma. Eur Rev Med Pharmacol Sci","volume":"26","author":"Xing","year":"2022"},{"key":"10.1016\/j.critrevonc.2025.105070_bib101","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1515552","article-title":"The biological function and prognostic significance of ferroptosis-related genes in clear cell renal cell carcinoma","volume":"16","author":"Ye","year":"2025","journal-title":"Front Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib102","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1186\/s12885-021-08559-0","article-title":"A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma","volume":"21","author":"Hong","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14712\/fb2022068010001","article-title":"Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma","volume":"68","author":"Liu","year":"2022","journal-title":"Folia Biol. (Praha)"},{"key":"10.1016\/j.critrevonc.2025.105070_bib104","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.2147\/IJGM.S354682","article-title":"Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma","volume":"15","author":"Chen","year":"2022","journal-title":"Int J. Gen. Med"},{"key":"10.1016\/j.critrevonc.2025.105070_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.912190","article-title":"A Prognostic Signature for Clear Cell Renal Cell Carcinoma Based on Ferroptosis-Related lncRNAs and Immune Checkpoints","volume":"13","author":"Dong","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.critrevonc.2025.105070_bib106","article-title":"Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.critrevonc.2025.105070_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.915372","article-title":"Establishment of a prognostic ferroptosis- and immune-related long noncoding RNAs profile in kidney renal clear cell carcinoma","volume":"13","author":"Han","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.critrevonc.2025.105070_bib108","article-title":"Establishing a prognostic model of ferroptosis- and immune-related signatures in kidney cancer: A study based on TCGA and ICGC databases","volume":"12","author":"Han","year":"2022","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib109","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12920-022-01418-2","article-title":"Construction of a ferroptosis-related signature based on seven lncRNAs for prognosis and immune landscape in clear cell renal cell carcinoma","volume":"15","author":"Wei","year":"2022","journal-title":"BMC Med Genom."},{"key":"10.1016\/j.critrevonc.2025.105070_bib110","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.14506","article-title":"Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma","volume":"10","author":"Ju","year":"2022","journal-title":"PeerJ"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib111","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41598-023-29305-5","article-title":"Ferroptosis-associated lncRNA prognostic signature predicts prognosis and immune response in clear cell renal cell carcinoma","volume":"13","author":"Lai","year":"2023","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.105070_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23464","article-title":"Analysis of lncRNAs profiles associated with ferroptosis can predict prognosis and immune landscape and drug sensitivity in patients with clear cell renal cell carcinoma","volume":"37","author":"Zong","year":"2023","journal-title":"J. Biochem Mol. Toxicol."},{"issue":"24","key":"10.1016\/j.critrevonc.2025.105070_bib113","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1002\/cam4.4395","article-title":"The roles of ferroptosis regulatory gene SLC7A11 in renal cell carcinoma: a multi-omics study","volume":"10","author":"Xu","year":"2021","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.105070_bib114","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10637-024-01472-w","article-title":"Clinical characteristics, treatment, and outcomes of nivolumab induced immune thrombocytopenia","volume":"42","author":"Peng","year":"2024","journal-title":"Invest N. Drugs"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/tau-22-663","article-title":"Potential upstream lncRNA-miRNA-mRNA regulatory network of the ferroptosis-related gene SLC7A11 in renal cell carcinoma","volume":"12","author":"Xu","year":"2023","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib116","article-title":"ACO1 and IREB2 downregulation confer poor prognosis and correlate with autophagy-related ferroptosis and immune infiltration in KIRC","volume":"12","author":"Zhu","year":"2022","journal-title":"Front Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib117","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1186\/s12885-022-10302-2","article-title":"CX3CL1 promotes cell sensitivity to ferroptosis and is associated with the tumor microenvironment in clear cell renal cell carcinoma","volume":"22","author":"Gong","year":"2022","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105070_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20020913","article-title":"Assessment of diagnosis, prognosis and immune infiltration response to the expression of the ferroptosis-related molecule HAMP in clear cell renal cell carcinoma","volume":"20","author":"Leng","year":"2023","journal-title":"Int. J. Environ. Res Public Health"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.105070_bib119","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24109092","article-title":"Single-cell RNA-Seq analysis reveals ferroptosis in the tumor microenvironment of clear cell renal cell carcinoma","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.105070_bib120","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.18632\/aging.205440","article-title":"LRP6 is a potential biomarker of kidney clear cell carcinoma related to prognosis and immune infiltration","volume":"16","author":"Lu","year":"2024","journal-title":"Aging (Albany NY)"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib121","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-024-01485-0","article-title":"ATF4\/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinoma","volume":"15","author":"Lu","year":"2024","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib122","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s12672-025-02283-y","article-title":"LPCAT3 regulates the immune infiltration and prognosis of ccRCC patients by mediating ferroptosis and endoplasmic reticulum stress","volume":"16","author":"Feng","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.critrevonc.2025.105070_bib123","doi-asserted-by":"crossref","first-page":"789","DOI":"10.34133\/research.0789","article-title":"PRMT5-mediated arginine methylation of ACSL4 attenuates its stability and suppresses ferroptosis in renal cancer","volume":"8","author":"Zhang","year":"2025","journal-title":"Res"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105070_bib124","first-page":"1232","article-title":"A prognostic model constructed by ferroptosis-associated genes (FAGs) in papillary renal cell carcinoma (PRCC) and its association with tumor mutation burden (TMB) and immune infiltration","volume":"27","author":"Chen","year":"2025","journal-title":"Clin. Transl. Oncol. Publ. Fed. Span. Oncol. Soc. Natl. Cancer Inst. Mex."},{"key":"10.1016\/j.critrevonc.2025.105070_bib125","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.2147\/IJGM.S354882","article-title":"Identification and validation of a ferroptosis-related signature for predicting prognosis and immune microenvironment in papillary renal cell carcinoma","volume":"15","author":"Da","year":"2022","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.critrevonc.2025.105070_bib126","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2147\/IJGM.S341034","article-title":"A novel ferroptosis-related lncRNA signature for prognosis prediction in patients with papillary renal cell carcinoma","volume":"15","author":"Dang","year":"2022","journal-title":"Int. J. Gen. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.105070_bib127","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/cimb46030123","article-title":"Ferroptosis-related lncRNA to predict the clinical outcomes and molecular characteristics of kidney renal papillary cell carcinoma","volume":"46","author":"Gong","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.105070_bib128","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1186\/s12885-023-11589-5","article-title":"Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Cancer"},{"issue":"23","key":"10.1016\/j.critrevonc.2025.105070_bib129","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1200\/JCO-25-00234","article-title":"Tumor-intrinsic and microenvironmental determinants of impaired antitumor immunity in chromophobe renal cell carcinoma","volume":"43","author":"Labaki","year":"2025","journal-title":"J. Clin. Oncol. J. Am. Soc. Clin. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825004585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842825004585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:41:52Z","timestamp":1770036112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842825004585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":129,"alternative-id":["S1040842825004585"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105070","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The crosstalk between ferroptosis and the immune system in urological cancers: Mechanisms, prognostic value, and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.105070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105070"}}